Warren Stone sold $277k of NEO
Pres & Chief Operating Officer at NEOGENOMICS INC. 22,128 shares at an average of $12.50, traded Jan 20, 2026, filed Jan 21, 2026.
Score components
- +20RoleCOO
- +14Trade size$277k at market
- +5Share of holdings soldSold 15% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -22.1%, 3m -35.5%, 6m +10.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-002970, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 20, 2026 | SOpen-market sale Common Stock10b5-1 | -22,128 | $12.50 | $277k | 121,631 | Jan 21, 2026 |
Related signals
Other insiders at NEOGENOMICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 49Moderate | NEOsell NEOGENOMICS INC | Greg D Aunan Chief Accounting Officer | $321k 20,000 shares | -80% | |
| 2Weak | NEOGENOMICS INC | Lynn A. Tetrault director | $59k 5,307 shares | -6% | |
| 2Weak | NEOGENOMICS INC | Lynn A. Tetrault director | $60k 5,307 shares | -5% | |
| 3Weak | NEOGENOMICS INC | Alicia C Olivo EVP, GC & Business Development | $251k 20,916 shares | -40% | |
| 7Weak | NEOGENOMICS INC | Alicia C Olivo EVP, GC & Business Development | $49k 4,918 shares | -10% | |
| 61Notable | NEOGENOMICS INC | Anthony P. Zook Chief Executive Officer | $100k 17,900 shares | +89% | |
| 51Moderate | NEOGENOMICS INC | Jeffrey Scott Sherman Chief Financial Officer | $112k 20,000 shares | +12% | |
| 37Weak | NEObuy NEOGENOMICS INC | Michael Aaron Kelly director | $38k 5,000 shares | - | |
| 53Moderate | NEOGENOMICS INC | Warren Stone Pres & Chief Operating Officer | $49k 5,700 shares | +6% | |
| 46Moderate | NEOGENOMICS INC | Stephen M Kanovsky director | $31k 4,000 shares | +11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.